TherapeuticsMD (TXMD) Retained Earnings (2010 - 2026)

TherapeuticsMD has reported Retained Earnings for 17 years, with the latest figure at -$952.3 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings changed 0.02% year-over-year to -$952.3 million; the trailing twelve-month figure through Mar 2026 stood at -$952.3 million (changed 0.02% YoY), and the FY2025 full-year result was -$952.4 million, changed 0.06% from the prior year.
• Retained Earnings for Q1 2026 stood at -$952.3 million, roughly flat from -$952.4 million in the prior quarter.
• The five-year high for Retained Earnings was -$939.4 million in Q4 2022, with the low at -$1.1 billion in Q1 2022.
• Historically, Retained Earnings has averaged -$964.6 million across 5 years, with a median of -$951.8 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings decreased 19.82% — and 2023, when it grew 14.31%.
• TherapeuticsMD's Retained Earnings stood at -$939.4 million in 2022, then retreated by 1.09% to -$949.6 million in 2023, then decreased by 0.23% to -$951.8 million in 2024, then decreased by 0.06% to -$952.4 million in 2025, then grew by 0.01% to -$952.3 million in 2026.
• The last three Retained Earnings figures came in at -$952.3 million (Q1 2026), -$952.4 million (Q4 2025), and -$951.8 million (Q3 2025), per Business Quant data.